Metrikler
Yayın
81
Açık Erişim
9
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
İç Hastalıkları
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (61)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (61)
ESCI (5)
Scopus (58)
TRDizin (6)
2024
20241. Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature
YÜCE SARI S., Yilmaz M. T., YAZICI G., Mohammadipour S., ÖZYİĞİT G., Gullu İ. H., et al.
STRAHLENTHERAPIE UND ONKOLOGIE
, sa.12, ss.1057-1065, 2024 (SCI-Expanded, Scopus)
2024
20242. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
AKYILDIZ A., GÜVEN D. C., KÖKSAL B., KARAOĞLAN B. B., Kivrak D., Ismayilov R., et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
, cilt.281, sa.9, ss.4991-4999, 2024 (SCI-Expanded, Scopus)
2024
20243. The Relationship Between Microplastics and Nanoplastics with Cancer: An Emerging Health Concern
Yazarkan Y., Sonmez G., Tenekeci A. K., AKSOY E. A., GÜLLÜ İ. H.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.34, sa.2, ss.102-112, 2024 (SCI-Expanded, Scopus, TRDizin)
2023
20234. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma
GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.
European Archives of Oto-Rhino-Laryngology
, cilt.280, sa.5, ss.2471-2478, 2023 (SCI-Expanded, Scopus)
2023
20235. Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.
Sari S., YİĞİT E., YAZICI G., GÜLLÜ İ. H., AKSOY S., ÖZYİĞİT G., et al.
Head & neck
, cilt.45, sa.3, ss.612-619, 2023 (SCI-Expanded, Scopus)
2023
20236. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma
ERUL E., Guven D. C., ÖZBAY Y., ALTUNBULAK A. Y., KAHVECİOĞLU A., ERCAN F., et al.
Biomarkers in medicine
, cilt.17, sa.2, ss.87-99, 2023 (SCI-Expanded, Scopus)
2022
20227. Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.
Sari S., Yilmaz M. T., Aktas B. Y., Aksoy S., Gullu İ. H., Cengiz M., et al.
Oral oncology
, cilt.124, ss.105658, 2022 (SCI-Expanded, Scopus)
2021
20218. A novel agnostic tumor: NTRKoma
Ayasun R., GÜVEN D. C., Gullu İ. H.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.27, sa.4, ss.802-803, 2021 (SCI-Expanded, Scopus)
2021
20219. Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report
Erul E., GÜVEN D. C., ŞAHİN T. K., Gullu İ. H.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.1, ss.98-101, 2021 (ESCI, Scopus, TRDizin)
2020
202010. Cancer incidence in Behcet's disease
GÜVEN D. C., BÖLEK E. Ç., ALTINTOP S. E., ÇELİKTEN B., AKTAŞ B. Y., KİRAZ S., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded, Scopus)
2020
202011. Outcome of Elderly Nasopharyngeal Carcinoma Patients: A Single Center Study
Basaran H., CENGİZ M., YAZICI G., Ozdemir Y., SÜTAY SÜSLÜ N., GÜLLÜ İ. H., et al.
EUROPEAN JOURNAL OF THERAPEUTICS
, cilt.26, sa.2, ss.129-134, 2020 (ESCI, TRDizin)
2020
202012. Cancer incidence in Behcet's Disease.
Guven D. C., Bolek E. C., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)
2019
201913. Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma
Basaran H., CENGİZ M., YAZICI G., Susulu N., AKSOY S., HOŞAL A. Ş., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.29, sa.3, ss.176-185, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201814. Human papillomavirus infection in patients with laryngeal carcinoma
Celebi O. O., Sener E., Hosal S., CENGİZ M., Gullu İ. H., Tezel G. G.
BMC CANCER
, cilt.18, 2018 (SCI-Expanded, Scopus)
2018
201815. The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer
YAZICI G., GÜLLÜ İ. H., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., et al.
Cureus
, cilt.10, ss.3519, 2018 (ESCI)
2016
201616. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer
Celebi O. O., Tezel G. G., Hosal A. S., CENGİZ M., GÜLLÜ İ. H., HAYRAN K. M.
PATHOLOGY RESEARCH AND PRACTICE
, cilt.212, sa.5, ss.456-462, 2016 (SCI-Expanded, Scopus)
2013
201317. Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents
Sarici F., Babacan T., Altundag K., Balakan O., Gullu I.
JOURNAL OF BUON
, cilt.18, sa.3, ss.799, 2013 (SCI-Expanded, Scopus)
2013
201318. Does Age Affect the Size of Metastatic Lymph Nodes in Head and Neck Cancer?
SÜSLÜ N., Hosal A. S., Tezel Y. G. G., Sozeri B., Gullu İ. H., Dolgun A.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.1, ss.13-19, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201219. Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine
Petekkaya I., Gezgen G., Roach E. C., Solak M., Altundag K., Gullu I.
JOURNAL OF BUON
, cilt.17, sa.4, ss.796, 2012 (SCI-Expanded, Scopus)
2012
201220. Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients
ŞENER DEDE D., AKSOY S., CENGİZ M., Gullu İ. H., Altundag K.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.13, sa.5, ss.2225-2228, 2012 (SCI-Expanded, Scopus)
2011
201121. Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer
BULUT N., AKSOY S., DİZDAR Ö., Dede D. S., Arslan C., DOĞAN E., et al.
MEDICAL ONCOLOGY
, cilt.28, 2011 (SCI-Expanded, Scopus)
2011
201122. A RETROSPECTIVE COMPARISON OF ROBOTIC STEREOTACTIC BODY RADIOTHERAPY AND THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY FOR THE REIRRADIATION OF LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA
ÖZYİĞİT G., CENGİZ M., YAZICI G., YILDIZ F., Gurkaynak M., Zorlu F., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.81, sa.4, 2011 (SCI-Expanded, Scopus)
2011
201123. SALVAGE REIRRADIATON WITH STEREOTACTIC BODY RADIOTHERAPY FOR LOCALLY RECURRENT HEAD-AND-NECK TUMORS
CENGİZ M., ÖZYİĞİT G., YAZICI G., DOĞAN A., YILDIZ F., Zorlu F., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.81, sa.1, ss.104-109, 2011 (SCI-Expanded, Scopus)
2011
201124. Sleep disturbance in patients with operable breast cancer receiving adjuvant hormone therapy
Aksoy S., Dede D. S., Yaman S., Ozkan C., Gullu İ. H., Altundag K.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201125. Clinicopathologic features of patients with breast cancer under teatment of bisphosphonate at the time of diagnosis: Retrospective analysis
Dede D. S., Arslan C., Aksoy S., Dizdar O., Dogan E., Alkan A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201126. Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer
Sari E., Guler G., HAYRAN K. M., Gullu İ. H., Altundag K., Ozisik Y.
MEDICAL ONCOLOGY
, cilt.28, sa.1, ss.57-63, 2011 (SCI-Expanded, Scopus)
2010
201027. Blood ABO groups and risk of breast cancer
ŞENER DEDE D., AKSOY S., DİZDAR Ö., Cerci P., Gullu İ. H., Ozisik Y., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1433, 2010 (SCI-Expanded, Scopus)
2010
201028. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature
KİTAPÇI M. T., Akkas B. E., Gullu İ. H., SÖKMENSÜER C.
ANNALS OF NUCLEAR MEDICINE
, cilt.24, sa.7, ss.549-553, 2010 (SCI-Expanded, Scopus)
2010
201029. Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis.
Ozen M., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
201030. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?
Aksoy S., Arslan C., Kurt M., Dizdar O., Dede D. S., Dogan E., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
201031. Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.
Surmell Z. G., Aksoy S., Dizdar O., Dede D. S., Dogan E., Arslan C., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
201032. Clinical and pathological characteristics of breast cancer patients with history of tonsillectomy
Isik M., AKSOY S., Dede D. S., DİZDAR Ö., Kara A., Gullu İ. H., et al.
BREAST
, cilt.19, sa.2, ss.152, 2010 (SCI-Expanded, Scopus)
2008
200833. Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases
Dincer M., Altundag K., Harputluoglu H., AKSOY S., CENGİZ M., Gullu İ. H.
MEDICAL ONCOLOGY
, cilt.25, sa.3, ss.356-359, 2008 (SCI-Expanded, Scopus)
2008
200834. Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience
Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
200835. Characteristics of breast cancer patients with central nervous system metastases: A single-center experience
Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded, Scopus)
2007
200736. Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management
Altundag K., ŞENER DEDE D., Harputluoglu H., Gullu İ. H.
JOINT BONE SPINE
, cilt.74, sa.6, ss.662-663, 2007 (SCI-Expanded, Scopus)
2007
200737. Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer
KURT M., Harputluoglu H., ŞENER DEDE D., GÜLLÜ İ. H., Altundag K.
BREAST
, cilt.16, sa.2, ss.111-112, 2007 (SCI-Expanded, Scopus)
2007
200738. Potential chemotherapy options in the triple negative subtype of breast cancer
Altundag K., Harputluoglu H., Aksoy S., Gullu İ. H.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.10, ss.1294-1295, 2007 (SCI-Expanded, Scopus)
2007
200739. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
Cengiz M., Zorlu F., Yalcin S., Gurkaynak M., Atahan I. L., Gullu İ. H.
MEDICAL ONCOLOGY
, cilt.24, sa.2, ss.239-243, 2007 (SCI-Expanded, Scopus)
2007
200740. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Turen S., Ozyar E., Altundag K., Gullu İ. H., Atahan I. L.
CANCER INVESTIGATION
, cilt.25, sa.5, ss.315-321, 2007 (SCI-Expanded, Scopus)
2006
200641. How would you manage a rare cause of haemoptysis?
Ulubay G., Gorek A., Akcay S., Gullu I.
BREATHE
, cilt.3, sa.2, ss.203-205, 2006 (ESCI, Scopus)
2006
200642. Mucosa associated lymphoid tissue lymphoma of the sub mandibular gland presenting with relapse in the lacrimal gland
KURT M., Shorbagi A., ALTUNDAĞ M. K., AKYÖN YILMAZ Y., DİZDAR Ö., GÜLLÜ İ. H.
Leukemia , cilt.47, ss.1982-1984, 2006 (SCI-Expanded)
2006
200643. Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient
Cankurtaran M., Ulger Z., Dogan S., Yavuz B., Halil M., Gullu I., et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH
, cilt.18, sa.1, ss.75-77, 2006 (SCI-Expanded, Scopus)
2006
200644. Peripheral T-cell lymphoma and Job's syndrome
Onal I., Kurt M., Altundag K., Aksoy S., Dincer M., Gullu I.
MEDICAL ONCOLOGY
, cilt.23, sa.1, ss.141-144, 2006 (SCI-Expanded, Scopus)
2005
200545. Metastatic biology
GÜLLÜ İ. H., Akalin I.
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
, cilt.4, sa.4, ss.16-19, 2005 (ESCI, Scopus, TRDizin)
2005
200546. Possible association between Budd-Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia
Kurt M., Shorbagi A., Altundag K., Elkiran T., Gullu I., Kansu E.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.80, sa.3, ss.213-215, 2005 (SCI-Expanded, Scopus)
2005
200547. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients
Altundag O., Gullu I., Altundag K., Yalcin S., Ozyar E., Cengiz M., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
, cilt.27, sa.1, ss.15-21, 2005 (SCI-Expanded, Scopus)
2005
200548. Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma
Kurt M., Onal I., Elkiran T., Altun B., Altundag K., Gullu I.
MEDICAL ONCOLOGY
, cilt.22, sa.2, ss.203-206, 2005 (SCI-Expanded, Scopus)
2004
200449. Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties
Aksoy S., Abali H., Dincer M., Kilickap S., Gullu I., Tekuzman G.
MEDICAL HYPOTHESES
, cilt.62, sa.6, ss.942-944, 2004 (SCI-Expanded, Scopus)
2004
200450. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis
Altundag O., Altundag K., Silay Y., Gunduz M., Demircan K., Gullu I.
MEDICAL HYPOTHESES
, cilt.63, sa.6, ss.1010-1013, 2004 (SCI-Expanded, Scopus)
2004
200451. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy
Altundag K., Aksoy S., Gullu I., Altundag O., Ozyar E., Yalcin S., et al.
MEDICAL ONCOLOGY
, cilt.21, sa.3, ss.211-215, 2004 (SCI-Expanded, Scopus)
2003
200352. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus)
2003
200353. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors
Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.
TUMORI
, cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus)
2002
200254. Effects of growth factors on doxorubicin-induced skin necrosis: Documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF
Vargel I., Erdem A., Ertoy D., Pinar A., Erk Y., Altundag M., et al.
ANNALS OF PLASTIC SURGERY
, cilt.49, sa.6, ss.646-653, 2002 (SCI-Expanded, Scopus)
2002
200255. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients
Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.
CHEMOTHERAPY
, cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus)
2002
200256. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
Abali H., Gullu İ. H., Engin H., Haznedaroglu I., Erman M., Tekuzman G.
MEDICAL HYPOTHESES
, cilt.59, sa.3, ss.344-348, 2002 (SCI-Expanded, Scopus)
2001
200157. Myasthenia gravis and lymphoblastic lymphoma involving the thymus: A rare association
Uner A., Abali H., Engin H., Akyol A., Ruacan E., Tan E., et al.
LEUKEMIA & LYMPHOMA
, cilt.42, sa.3, ss.527-531, 2001 (SCI-Expanded, Scopus)
2000
200058. Primary breast lymphomas - A retrospective analysis of twelve cases
Barista I., Baltali E., Tekuzman G., Kars A., Ruacan S., Ozisik Y., et al.
ACTA ONCOLOGICA
, cilt.39, sa.2, ss.135-139, 2000 (SCI-Expanded, Scopus)
2000
200059. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy
Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.
JOURNAL OF SURGICAL ONCOLOGY
, cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)
1997
199760. Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma
Kars A., Celik İ., Kansu E., Tekuzman G., Ozisik Y., Guler N., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.59, sa.2, ss.100-104, 1997 (SCI-Expanded, Scopus)
1996
199661. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections
Akova M., Ozcebe O. İ., Gullu I., Unal S., GUR D., AKALIN S., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.8, sa.4, ss.284-289, 1996 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).
Akyildiz A., Guven D. C., Koksal B., Karaoglan B. B., Salim D. K., Sutcuoglu O., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)
2018
20182. Adjuvan Yoğunluk Ayarlı Radyoterapi Uygulanan Baş-Boyun Kanserli Olgularda Tedavi Sonuçlarımız.
YÜCE SARI S., CENGİZ M., YAZICI G., ELMALI DOĞAN A., BEDÜK Ç. S., GÜLLÜ İ. H., et al.
13.Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri)
2018
20183. Baş-Boyun Melanomlarında Radyoterapi Sonuçlarımız
YÜCE SARI S., YAZICI G., CENGİZ M., YILMAZ M. T., AKSOY S., GÜLLÜ İ. H., et al.
13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Türkiye, 27 Nisan - 01 Mayıs 2018, (Tam Metin Bildiri)
2017
20174. Definitif Radyoterapi Uygulanan Lokal İleri Evre Larinks Kanserli Hastalarda Hematolojik Parametrelerin Sağkalım Üzerine Prognostik Etkisi
YÜCE SARI S., CENGİZ M., GÜLTEKİN M., SÜSLÜ N., YAZICI G., HAYRAN K. M., et al.
22. UKK, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
2016
20165. Survival and Larynx Preservation Rates after Definitive Radiotherapy A Single Center Experience
CENGİZ M., YÜCE SARI S., GÜLTEKİN M., SÜSLÜ N., AKSOY S., KUŞCU O., et al.
ECHNO 2016, Budapest, Macaristan, 7 - 10 Eylül 2016, (Özet Bildiri)
2016
20166. The impact of the total size of lesions in multifocal multicentric breast cancer on survival
Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
20167. Modified docetaxel cisplatin and fluorouracil therapy as a first line treatment for patients with recurrent metastatic squamous cell carcinoma of the head and neck cancer a retrospective study
DEMİRCİ N., AKSOY S., ÖZDEMİR N., Babacan T., ERDEM G. U., BOZKAYA Y., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
20168. The impact of the total size of lesions in multifocal/multicentric breast cancer on survival.
Karakas Y., Dizdar O., Akin S., Ates O., Sendur M. A. N., Aksoy S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)
2015
20159. Radiation Therapy Results of Patients With Adenoid Cystic Carcinoma
GÜLTEKİN M., CENGİZ M., Sari S. Y., HOŞAL Ş., YAZICI G., SÜSLÜ N., et al.
57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, cilt.93, (Özet Bildiri)
2014
201410. Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.
Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201311. Early stage "T2N0" breast cancer: Does it consist two different "T2" stages?
Arslan C., Sahin U., Kizilarslanoglu C., Solak M., Gullu I. H., Ozisik Y., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201312. Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.
Altundag K., Aksoy S., Sendur M. A. N., Guler E. N., Gullu I. H., Ozisik Y. Y.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2009
200913. Comparison of ER, PR, HER2 in primary and paired relapsed/metastatic lesions of metastatic breast cancer patients
SARI E., Guler G., HAYRAN K. M., Altundag K., GÜLLÜ İ. H., Ozisik Y.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2009
200914. Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis
Dede D. S., Aksoy S., Bulut N., Dizdar O., Arik Z., Gullu I., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2007
200715. Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis
Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.
30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri)
2004
200416. Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy
Turen S., Ozyar E., Altundag K., Gullu I., Atahan I.
23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology (ESTRO 23), Amsterdam, Hollanda, 24 - 28 Ekim 2004, cilt.73, (Özet Bildiri)
2004
200417. Clinicopathological features and outcome of primary gastric lymphoma: A series of 73 cases
Oyan B., Tekuzman G., Barista I., Kars A., Turker A., Ozisik Y., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)